PCR Assay Articles & Analysis

Immundiagnostik's respiratroy PCR assays MutaPLEX® Coronavirus (KG1926), MutaPLEX® RespiraScreen 1 (KG1927), MutaPLEX® RespiraScreen 2 DIFF (KG1928) and MutaPLEX® Coronavirus 4G (KG1936) were screened for the spike protein mutations in the following viral variants: [Omicron] (BA.1, BA.2, BA.4, BA.5) [Omicron] (BA.3, BA.2 + L452X) [Alpha], [Beta], [Gamma], [Delta] (all AY ...

By Immundiagnostik AG

The JRC released a new reference material for the detection of SARS-CoV-2 by real time RT-PCR. The material consists of a synthetic ssRNA (EURM-014) covering a fraction of the viral genome. It will be particularly useful for clinical or environmental diagnostic laboratories seeking quality and trust in their SARS-CoV-2 measurements. In 2020, the JRC issued a synthetic ssRNA molecule (EURM-019) ...

By European Commission, Joint Research Centre (JRC)

Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant genetic diversity since it first entered the human population. This led to the emergence of numerous variants, some of them recently being labeled “variants of concern” (VOC), due to their potential impact ...

By Vitassay Healthcare, S.L.U.

ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB kit, a high-performance, qualitative, multiplex assay for the rapid detection of the Carbapenem Resistance genes of Enterobacteriaceae. In combination with the ELITe InGenius™, the ELITech Group’s fully automated sample-to-result system, the assay is intended to detect 150 variants belonging to ...

By ELITechGroup

During this pandemic situation, erratic supply of lab wares and reagents, as well as bottlenecks created due to high demand and short supply of the test reagents, has created a delay in getting the population tested for COVID-19. Worldwide calls for widespread testing has skyrocketed the amount of requests for PCR reagent supply. Current real-time PCR assays and PCR instruments consume large ...

By Lumex Instruments

The current pandemic situation has created a demand for test kits that can be run with less amount of reagents while generating faster test results.Lumex Instruments’ microchip real-time PCR analyzer AriaDNA, by detecting SARS-CoV-2, has proven its ability to meet this demand. The Microchip RT-PCR COVID-19 Detection System based on AriaDNA enables to test up to seven patient samples in one ...

By Lumex Instruments

Thermo Fisher Scientific, the world leader in serving science, today announced an update to its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to enable direct detection of the Omicron SARS-CoV-2 variant. The panel is designed with a customizable menu of real-PCR genotyping assays to accurately identify known SARS-COV-2 variants in just over an hour. South African researchers first ...

By Thermo Fisher Scientific

Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, is excited to announce the launch of its PCR toolboxes, including rapid PCR kits, enzymes, reagents, and assays. These PCR products will empower researchers in their pursuit of groundbreaking discoveries, providing convenience and ensuring high-quality results in ...

By Amerigo Scientific

The new Vitassay Real Time PCR allows the qualitative detection of SARS-CoV-2 and the HV 69/70 deletion of the S gene for SARS-CoV-2 in respiratory samples. Several SARS-CoV-2 variants of concern (VOC) have emerged in the past months and monitoring them in all countries is key. The United Kingdom (UK) has detected a new variant of SARS-CoV-2 from samples initially taken in Kent on September 20th ...

By Vitassay Healthcare, S.L.U.

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit*, and TaqPath COVID-19 CE-IVD RT-PCR Kit*, which test for the presence of SARS-CoV-2, are not impacted by the emerging B.1.1.529, or Omicron variant, enabling accurate test results. The Omicron variant, which was designated a "variant ...

By Thermo Fisher Scientific

Lumex Instruments has developed a rapid modern solution to distinguish COVID-19, Influenza A, and B from the same sample.* It is imperative to differentiate and identify the exact causative virus for appropriate therapeutic intervention, especially during the current COVID-19 pandemic. The solution employs a pre-loaded microchip kit with the primers and probes lyophilized in the microchip for ...

By Lumex Instruments

Quark Biosciences Inc. announced today the successful development of a novel digital PCR test, DigiChip SARS-CoV-2 Assay, that is 10x more sensitive than conventional diagnostic methods. The company plans to work with Shin Kong Memorial Hospital and a California-based medical group for clinical validation and to apply for regularly approval. The assay is capable of detecting ...

By Quark Biosciences, Inc.

As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a series of NiV recombinant antigen and antibody pairs. All of these new products are produced using standardized production processes to ensure the highest quality. Tests developed using these reagents can assist researchers in routine diagnostics and NiV ...

By Creative Diagnostics